FEB 20, 2019 03:00 PM PST

Possible New Drug To Combat African Sleeping Sickness

WRITTEN BY: Nouran Amin

Scientists have teamed up to combat African sleeping sickness, which is caused by trypanosomes, unicellular protozoans transmitted by the bite of an infected tsetse fly. They specifically discovered how an inhibitory substance docks on the parasite to deactivate one of its vital proteins. "There is still a long way to go before we arrive at a pharmaceutical product," says Professor Ute Hellmich of Johannes Gutenberg University Mainz (JGU). "But our highly interdisciplinary work involving parasitology, theoretical and organic chemistry, structural biology, and biochemistry has shown how the parasite that causes sleeping sickness can be rendered harmless."

African sleeping sickness affected about 15,000 in 2014. It is challenging to differentiate the infection from malaria as they both have similar symptoms in the early stages. "Not only the poorest people in sub-Saharan Africa are threatened, but also their cattle, which are affected on a dramatic scale by certain species of Trypanosoma brucei," explained biochemist Professor Ute Hellmich.

Learn more:

As of now, only a handful of drugs seek to treat the sleeping sickness, which is fatal if untreated. However, even though new drugs are in development, the approach in the new study goes one step further: "Our inhibitor opens up the future prospect of being able to design inhibitors on a fundamental level and could thus possibly also be used in the treatment of infection with other, related pathogenic parasites, such as Leishmania," says lead author, Annika Wagner.

"We were astonished and initially thought it was a chance effect due to experimental conditions," said Hellmich. "Instead, we took a second look at the result and then discussed it with experts from different fields. Research only progresses when we work together."

Source: Johannes Gutenberg Universitaet Mainz

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
OCT 22, 2019
Cell & Molecular Biology
OCT 22, 2019
How the Kava Plant Creates Medicinal Compounds
Nature has given us some of our best medicines; it's thought that as many as half the drugs we used are derived from natural products....
OCT 22, 2019
Immunology
OCT 22, 2019
A New Way To Fight Severe Peanut Allergies
Dr. Sandra Lin explains how SLIT is currently being used to treat allergies other than peanuts.    Over 1 million U.S. children have an allergy t...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Do Nootropics Really Boost Brain Function?
  Nootropics are a broad range of both natural and artificial compounds though to improve cognitive function. Including everything from caffeine to Ad...
OCT 22, 2019
Cannabis Sciences
OCT 22, 2019
CBD Alleviates Angelman Syndrome Seizures in Mice Trial
CBD has already been shown to be effective as an anti-anxiety, antipsychotic and anti-epileptic substance. Can it help youth and adults with a rare neurolo...
OCT 22, 2019
Cancer
OCT 22, 2019
An alternative for immunotherapy-resistant cancer patients
A twist to traditional immunotherapies could help cancer patients’ immune systems better detect cancer cells, making this new system capable of targe...
Loading Comments...